YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment

Xiaochen Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yung‐Chi Cheng(Yale University)

Scientific Reports

June 29, 2021

10.1038/s41598-021-91623-3

Cited by 32

Related Papers

Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment

|BMC Medical Genomics|2011|71

DCB-3503, a Tylophorine Analog, Inhibits Protein Synthesis through a Novel Mechanism

|PLoS ONE|2010|23

YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity

|Frontiers in Pharmacology|2023|8

YIV-906 Potentiated anti-PD1 Action Against Hepatocellular Carcinoma by Enhancing Adaptive and Innate Immunity in the Tumor Microenvironment.

|Research Square|2021|4